ENDRA Life Sciences Inc. - 8-K Filing
ENDRA Life Sciences Inc. entered into an Agreement and Plan of Merger on June 25, 2026, with ASP Isotopes Inc., Noble Africa LLC, Renergen Limited, and Kruger Merger Sub LLC to merge Kruger Merger Sub with Noble, resulting in a restructured ownership under ENDRA as the parent company. Concurrently, Noble raised $50 million through subscription agreements for Class A and B units prior to closing. (Items: 1.01 of this Current Report on Form 8-K is incorporated herein by reference, 9.01 Financial Statements and Exhibits)
Tickers: $NDRA